Comparison of the efficacy and safety of two starting dosages of prednisolone in early active rheumatoid arthritis (CORRA): study protocol for a randomized controlled trial

[1] Kirwan JR(1995)The effect of glucocorticoids on joint destruction in rheumatoid-arthritis N Engl J Med 333 142-146

[2] Byron M(2006)Safety of low dose glucocorticoid treatment in rheumatoid arthritis: published evidence and prospective trial data Ann Rheum Dis 65 285-293

[3] Dieppe P(2009)Adverse events of low- to medium-dose oral glucocorticoids in inflammatory diseases: a meta-analysis Ann Rheum Dis 68 1833-1838

[4] Eastmond C(2012)Low-dose prednisone inclusion in a methotrexate-based, tight control strategy for early rheumatoid arthritis a randomized trial Ann Intern Med 156 329-391

[5] Halsey J(2005)Low-dose prednisolone in addition to the initial disease-modifying antirheumatic drug in patients with early active rheumatoid arthritis reduces joint destruction and increases the remission rate: a two-year randomized trial Arthritis Rheum 52 3360-3370

[6] Hickling P(2002)Low-dose prednisone therapy for patients with early active rheumatoid arthritis: clinical efficacy, disease-modifying properties, and side effects: a randomized, double-blind, placebo-controlled clinical trial Ann Intern Med 136 1-12

[7] Hollingworth P(2005)Very low-dose prednisolone in early rheumatoid arthritis retards radiographic progression over two years: a multicenter, double-blind, placebo-controlled trial Arthritis Rheum 52 3371-3380

[8] Jacoby R(1997)Randomised comparison of combined step-down prednisolone, methotrexate and sulphasalazine with sulphasalazine alone in early rheumatoid arthritis Lancet 350 309-318

[9] Kirk A(2005)Clinical and radiographic outcomes of four different treatment strategies in patients with early rheumatoid arthritis (the BeSt study): a randomized, controlled trial Arthritis Rheum 52 3381-3390

[10] Moran C(2011)Glucocorticoid treatment in early rheumatoid arthritis Clin Exp Rheumatol 29 S121-S125

[1] Kirwan JR(1995)The effect of glucocorticoids on joint destruction in rheumatoid-arthritis N Engl J Med 333 142-146

[2] Byron M(2006)Safety of low dose glucocorticoid treatment in rheumatoid arthritis: published evidence and prospective trial data Ann Rheum Dis 65 285-293

[3] Dieppe P(2009)Adverse events of low- to medium-dose oral glucocorticoids in inflammatory diseases: a meta-analysis Ann Rheum Dis 68 1833-1838

[4] Eastmond C(2012)Low-dose prednisone inclusion in a methotrexate-based, tight control strategy for early rheumatoid arthritis a randomized trial Ann Intern Med 156 329-391

[5] Halsey J(2005)Low-dose prednisolone in addition to the initial disease-modifying antirheumatic drug in patients with early active rheumatoid arthritis reduces joint destruction and increases the remission rate: a two-year randomized trial Arthritis Rheum 52 3360-3370

[6] Hickling P(2002)Low-dose prednisone therapy for patients with early active rheumatoid arthritis: clinical efficacy, disease-modifying properties, and side effects: a randomized, double-blind, placebo-controlled clinical trial Ann Intern Med 136 1-12

[7] Hollingworth P(2005)Very low-dose prednisolone in early rheumatoid arthritis retards radiographic progression over two years: a multicenter, double-blind, placebo-controlled trial Arthritis Rheum 52 3371-3380

[8] Jacoby R(1997)Randomised comparison of combined step-down prednisolone, methotrexate and sulphasalazine with sulphasalazine alone in early rheumatoid arthritis Lancet 350 309-318

[9] Kirk A(2005)Clinical and radiographic outcomes of four different treatment strategies in patients with early rheumatoid arthritis (the BeSt study): a randomized, controlled trial Arthritis Rheum 52 3381-3390

[10] Moran C(2011)Glucocorticoid treatment in early rheumatoid arthritis Clin Exp Rheumatol 29 S121-S125